Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (351-360 of 1,137) with videos related to

Pageof 114
Sort By:
Oecologia|March 18, 2017
The effects of oxalates produced by Salsola tragus on the phosphorus nutrition of Stipa pulchraJ P Cannon, E B Allen, M F Allen, et al.
Human Gene Therapy|September 1, 1995
In vivo marking of spontaneous or vaccine-induced fibrosarcomas in the domestic house cat, using an adenoviral vector containing a bifunctional fusion protein, GAL-TEKF C Marini, J P Cannon, J W Belmont, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 19, 2020
The multiplication of loaves and fishes approach: a critic to double anti-thrombotics or to double number of ischaemic events?Giuseppe Gargiulo, Christopher P Cannon, Charles Michael Gibson, et al.
The American Journal of Medicine|March 28, 2018
Alogliptin in Patients with Type 2 Diabetes Receiving Metformin and Sulfonylurea Therapies in the EXAMINE TrialWilliam B White, Simon R Heller, Christopher P Cannon, et al.
Journal of the American College of Cardiology|August 18, 2004
A risk score to estimate the likelihood of coronary artery bypass surgery during the index hospitalization among patients with unstable angina and non-ST-segment elevation myocardial infarctionSaihari Sadanandan, Christopher P Cannon, C Michael Gibson, et al.
The American Journal of Cardiology|June 29, 2002
Comparison of errors in estimating weight and in dosing of single-bolus tenecteplase with tissue plasminogen activator (TIMI 10B and ASSENT I)Sabina A Murphy, C Michael Gibson, Frans Van de Werf, et al.
Australian Dental Journal|May 4, 2006
Analysis of the acute postoperative pain experience following oral surgery: identification of 'unaffected', 'disabled' and 'depressed, anxious and disabled' patient clustersE R Vickers, H Boocock, R D Harris, et al.
American Heart Journal|May 3, 2005
Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trialCharles S Smith, Christopher P Cannon, Carolyn H McCabe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 4, 2010
Cutting edge: FcR-like 6 is an MHC class II receptorDaniel M Schreeder, John P Cannon, Jiongru Wu, et al.
The American Journal of Cardiology|September 18, 2004
Usefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS)David A Morrow, Marc S Sabatine, Elliott M Antman, et al.
Pageof 114

Showing results (351-360 of 1,137) with videos related to

Sort By:
Pageof 114
Oecologia|March 18, 2017
The effects of oxalates produced by Salsola tragus on the phosphorus nutrition of Stipa pulchraJ P Cannon, E B Allen, M F Allen, et al.
Human Gene Therapy|September 1, 1995
In vivo marking of spontaneous or vaccine-induced fibrosarcomas in the domestic house cat, using an adenoviral vector containing a bifunctional fusion protein, GAL-TEKF C Marini, J P Cannon, J W Belmont, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 19, 2020
The multiplication of loaves and fishes approach: a critic to double anti-thrombotics or to double number of ischaemic events?Giuseppe Gargiulo, Christopher P Cannon, Charles Michael Gibson, et al.
The American Journal of Medicine|March 28, 2018
Alogliptin in Patients with Type 2 Diabetes Receiving Metformin and Sulfonylurea Therapies in the EXAMINE TrialWilliam B White, Simon R Heller, Christopher P Cannon, et al.
Journal of the American College of Cardiology|August 18, 2004
A risk score to estimate the likelihood of coronary artery bypass surgery during the index hospitalization among patients with unstable angina and non-ST-segment elevation myocardial infarctionSaihari Sadanandan, Christopher P Cannon, C Michael Gibson, et al.
The American Journal of Cardiology|June 29, 2002
Comparison of errors in estimating weight and in dosing of single-bolus tenecteplase with tissue plasminogen activator (TIMI 10B and ASSENT I)Sabina A Murphy, C Michael Gibson, Frans Van de Werf, et al.
Australian Dental Journal|May 4, 2006
Analysis of the acute postoperative pain experience following oral surgery: identification of 'unaffected', 'disabled' and 'depressed, anxious and disabled' patient clustersE R Vickers, H Boocock, R D Harris, et al.
American Heart Journal|May 3, 2005
Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trialCharles S Smith, Christopher P Cannon, Carolyn H McCabe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 4, 2010
Cutting edge: FcR-like 6 is an MHC class II receptorDaniel M Schreeder, John P Cannon, Jiongru Wu, et al.
The American Journal of Cardiology|September 18, 2004
Usefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS)David A Morrow, Marc S Sabatine, Elliott M Antman, et al.
Pageof 114